DavidNLouisMD

Neuropathology, Anatomic Pathology, Clinical Pathology

Pathologist-in-Chief and Benjamin Castleman Professor of Pathology, Massachusetts General Hospital and Harvard Medical School

Dr. Louis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
55 Fruit St
Wrn 2
Boston, MA 02114
Phone+1 617-726-2966

Fax+1 617-726-7533

Massachusetts General HospitalFellowship, Neuropathology, 1989 - 1991
Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1987 - 1989
Albany Medical CenterResidency, Internal Medicine, 1985 - 1987
Stony Brook University Health Sciences Center School of MedicineClass of 1985

Lead editor World Health Organization Classification of Tumours of the Central Nervous System, 2007, 2016
Super Doctor SuperDoctors.com

PubMed

4767 citations
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
David N. Louis, Arie Perry, Pieter Wesseling, Daniel J. Brat, Ian A. Cree
Neuro-Oncology. 2021-08-02
548 citations
cIMPACT-NOW Update 3: Recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
Daniel J. Brat, Kenneth Aldape, Howard Colman, Eric C. Holland, David N. Louis
Acta Neuropathologica. 2018-11-01
298 citations
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.
Daniel J. Brat, Kenneth Aldape, Howard Colman, Dominique Figrarella-Branger, Gregory N. Fuller
Acta Neuropathologica. 2020-01-29

Other

Classification of gliomas
Louis DN, Schiff D, Batchelor T
http://www.uptodate.com/contents/classification-of-gliomas
UpToDate, Wolters Kluwer Health - 2012-12-20
Pathogenesis and biology of malignant gliomas
Louis DN, Batchelor T
http://www.uptodate.com/contents/pathogenesis-and-biology-of-malignant-gliomas
UpToDate, Wolters Kluwer Health - 2012-02-14

Testing for COVID-19 Antibodies May Show How Widespread Pandemic Is in BostonApril 27th, 2020
AI Set to Transform Digital Pathology for Hospitals, Says Frost & SullivanFebruary 25th, 2019
Philips Collaborates with Two Boston-Based Academic Medical Centers to Advance Digital Pathology Adoption Across the U.S.March 20th, 2018
Join now to see all

Toward A Molecular Classification Of Human GliomasNational Cancer Institute2009–2012
Neuropathology CoreNational Cancer Institute2008–2011
Molecular Immunology And Tumor BiologyNational Cancer Institute2001–2011
Neuropathology &Molecular Genetics CoreNational Cancer Institute2006–2010
Custom Array CGH For Glioma Diagnosis And ManagementNational Cancer Institute2007–2009
Toward A Molecular Classification Of Human GliomasNational Cancer Institute1999–2008
Custom Array CGH For Glioma Diagnosis And ManagementNational Cancer Institute2005–2006
Core--Neuropathology And Brain Tumor BankNational Institute Of Neurological Disorders And Stroke2001–2002
Core--Neuropathology And Molecular Genetics FacilityNational Cancer Institute2000–2002
Chromosome 19q Glioma Tumor Suppressor GeneNational Cancer Institute1996–2002
Core--NeuropathologyNational Institute Of Neurological Disorders And Stroke1996–1999
Core--Neuropathology FacilityNational Cancer Institute1996–1999
Tumor Suppressor Genes In AstrocytomasNational Cancer Institute1991–1992